Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 208.09 billion. The enterprise value is 230.84 billion.

Market Cap	208.09B
Enterprise Value	230.84B

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Mar 17, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.24%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.52B

Valuation Ratios

The trailing PE ratio is 12.59.

PE Ratio	12.59
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	26.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.48, with an EV/FCF ratio of 13.21.

EV / Earnings	13.96
EV / Sales	3.90
EV / EBITDA	8.48
EV / EBIT	10.05
EV / FCF	13.21

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.83.

Current Ratio	1.36
Quick Ratio	0.87
Debt / Equity	0.83
Debt / EBITDA	1.30
Debt / FCF	2.11
Interest Coverage	19.58

Financial Efficiency

Return on equity (ROE) is 40.79% and return on invested capital (ROIC) is 19.62%.

Return on Equity (ROE)	40.79%
Return on Assets (ROA)	13.90%
Return on Invested Capital (ROIC)	19.62%
Return on Capital Employed (ROCE)	28.06%
Revenue Per Employee	837,566
Profits Per Employee	223,423
Employee Count	75,000
Asset Turnover	0.57
Inventory Turnover	2.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.30% in the last 52 weeks. The beta is 0.36, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-32.30%
50-Day Moving Average	86.67
200-Day Moving Average	99.17
Relative Strength Index (RSI)	40.29
Average Volume (20 Days)	3,373

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.33

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 61.98 billion and earned 16.53 billion in profits. Earnings per share was 6.51.

Revenue	61.98B
Gross Profit	47.78B
Operating Income	24.04B
Pretax Income	19.26B
Net Income	16.53B
EBITDA	28.14B
EBIT	24.04B
Earnings Per Share (EPS)	6.51

Full Income Statement

Balance Sheet

The company has 13.22 billion in cash and 36.96 billion in debt, giving a net cash position of -23.74 billion.

Cash & Cash Equivalents	13.22B
Total Debt	36.96B
Net Cash	-23.74B
Net Cash Per Share	n/a
Equity (Book Value)	44.79B
Book Value Per Share	17.70
Working Capital	10.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.74 billion and capital expenditures -3.26 billion, giving a free cash flow of 17.48 billion.

Operating Cash Flow	20.74B
Capital Expenditures	-3.26B
Free Cash Flow	17.48B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.09%, with operating and profit margins of 38.79% and 26.68%.

Gross Margin	77.09%
Operating Margin	38.79%
Pretax Margin	31.07%
Profit Margin	26.68%
EBITDA Margin	45.40%
EBIT Margin	38.79%
FCF Margin	28.20%

Dividends & Yields

This stock pays an annual dividend of 2.93, which amounts to a dividend yield of 3.55%.

Dividend Per Share	2.93
Dividend Yield	3.55%
Dividend Growth (YoY)	5.70%
Years of Dividend Growth	7
Payout Ratio	45.80%
Buyback Yield	0.24%
Shareholder Yield	3.79%
Earnings Yield	7.95%
FCF Yield	8.40%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a